Oncology real-world data and research – breast cancer edition
As a HEOR leader, you know how critical real-world data (RWD) and evidence (RWE) are for understanding treatment patterns, outcomes and the true impact of new therapies. This breast cancer-focused research booklet curates 12 studies that leverage Ontada’s oncology RWD to uncover meaningful insights.
What’s inside:
- Characterization of real-world treatment patterns and outcomes for patients with HER2-negative early breast cancer, including by BRCA mutation status
- Evaluation of real-world tumor response and survival with palbociclib plus aromatase inhibitor in metastatic breast cancer
- Assessment of social determinants of health (SDOH) and their impact on use of genetic testing and neoadjuvant chemotherapy in triple-negative breast cancer
By harnessing the power of RWE, these studies can help inform your organization’s oncology HEOR efforts.
Download the breast cancer booklet to uncover insights into treatment patterns, outcomes and social determinants of health.